文献速递颅颌面外科创面修复

合成HA/TCP联合rhBMP-2与自体骨移植行牙槽骨植骨的结果比较

Alveolar Bone Grafting: Outcomes Utilizing Synthetic HA/TCP and rhBMP-2 versus Autologous Graft Types.
PubMed 文献 · Plast Reconstr Surg · 2025-06-17

本回顾性队列研究纳入118例因唇腭裂牙槽嵴缺损行牙槽骨植骨的患者,比较自体髂骨移植、自体髂骨联合rhBMP-2及15%HA/TCP联合rhBMP-2三组的再植骨需求和移植成活率。结果显示HA/TCP联合rhBMP-2组再植骨率与其他组相似,中位移植成活百分比更高,并发症率总体相似,但术后面部肿胀率高于ICBG组。

要点

  • HA/TCP联合rhBMP-2组的再植骨需求与自体骨移植组相似。
  • HA/TCP联合rhBMP-2组中位移植成活率68.0%,高于ICBG组25.1%和ICBG+rhBMP-2组44.2%。
  • HA/TCP联合rhBMP-2组术后面部肿胀率高于ICBG组(OR 6.8)。

核心结论

  • HA/TCP联合rhBMP-2可作为牙槽骨植骨的可行替代方案,成功率与ICBG及ICBG联合rhBMP-2相当,移植成活率更高且除面部肿胀外未增加并发症风险。

研究设计与样本

  • 回顾性队列研究,通过CPT代码识别118例行牙槽骨植骨的患者,分为ICBG组(n=37)、ICBG联合rhBMP-2组(n=65)和15%HA/TCP联合rhBMP-2组(n=16)。

主要发现

  • HA/TCP联合rhBMP-2组再植骨需求率与其他组相似。
  • HA/TCP联合rhBMP-2组中位移植成活百分比为68.0%(IQR 45.9%–93.1%),高于ICBG组的25.1%(IQR 5.2%–43.5%;Z=3.16;P=0.002)和ICBG联合rhBMP-2组的44.2%(IQR 24.5%–63.1%;Z=2.19;P=0.028)。
  • 各组并发症率相似(裂开P=0.319;手术部位感染P=0.357),但HA/TCP联合rhBMP-2组术后面部肿胀率高于ICBG组(OR 6.8;95%CI 1.44–32.00;P=0.0157)。

临床怎么用

  • 对于唇腭裂牙槽嵴缺损需行牙槽骨植骨者,可考虑使用15%HA/TCP联合rhBMP-2作为自体骨移植的替代方案,但需注意术后面部肿胀风险可能高于单纯ICBG。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Alveolar ridge defects associated with cleft lip and palate are typically repaired using alveolar bone grafting (ABG), with autologous grafting as the standard despite donor-site morbidity. This study investigated outcomes of using hydroxyapatite/ß-tricalcium phosphate (HA/TCP) as a synthetic graft alternative. METHODS: A retrospective cohort study identified 118 patients who underwent ABG by means of CPT codes and were divided into 3 groups: autologous iliac crest bone graft (ICBG) ( n = 37), ICBG plus recombinant human bone morphogenetic protein-2 (rhBMP-2) ( n = 65), and 15% HA/TCP plus rhBMP-2 ( n = 16). Primary outcomes included need for regrafting and percentage graft take, assessed by means of cone beam computed tomographic imaging. Secondary outcomes included complication rates (swelling, wound dehiscence, surgical-site infection) and perioperative data (surgery length, hospital stay). RESULTS: Patients who received HA/TCP plus rhBMP-2 experienced similar rates of need for regrafting to the other groups. The median percentage graft take was higher for HA/TCP plus rhBMP-2 (68.0%; interquartile range [IQR], 45.9% to 93.1%) compared with ICBG (25.1%; IQR, 5.2% to 43.5%; Z = 3.16; P = 0.002) and ICBG plus rhBMP-2 (44.2%; IQR, 24.5% to 63.1%; Z = 2.19; P = 0.028). Complication rates were similar across groups (dehiscence, P = 0.319; surgical-site infection, P = 0.357), except for a higher rate of postsurgical facial swelling for HA/TCP plus rhBMP-2 compared with ICBG (OR, 6.8; 95% CI, 1.44 to 32.00; P = 0.0157). CONCLUSION: HA/TCP plus rhBMP-2 is a viable alternative to ABG, showing comparable success to ICBG and ICBG plus rhBMP-2, with superior percentage graft take and no increased complication risk, aside from increased postsurgical facial swelling compared with ICBG.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Kahan RH, Palmer SK, Garoosi K, et al. Alveolar Bone Grafting: Outcomes Utilizing Synthetic HA/TCP and rhBMP-2 versus Autologous Graft Types. Plast Reconstr Surg. 2025. PMID: 40532212. doi:10.1097/PRS.0000000000012257

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。